Integrated Project Services, LLC (IPS) and G-CON Manufacturing’s iCON™ Turnkey Facility Selected by MilliporeSigma for End-to-End Modular mAb Manufacturing Platform

Share Article

The collaboration of the three companies brings significant experience and products together to provide the most comprehensive turnkey platform for speeding access to biologics worldwide.

MilliporeSigma’s choice to offer a 2,000L iCON facility to their end-to-end customers validates the innovation and flexibility of iCON platform.

MilliporeSigma, the operating entity in the US and Canada for the life science business of Merck KGaA, Darnstadt Germany, has selected the iCON™ turnkey modular facility solution, launched last year by IPS-Integrated Project Services, LLC (IPS) and G-CON Manufacturing, Inc. (G-CON), in its efforts to provide the most advanced 2,000L monoclonal antibody (mAb) facility and single use process technology platform.

The iCON collaboration combines a broad range of technical capabilities in engineering, process development and biologics production along with prefabricated cleanroom PODs for a true turnkey solution to MilliporeSigma’s clients who require commercial production and capacity flexing capability.

“MilliporeSigma’s choice to offer a 2,000L iCON facility to their end-to-end customers validates the innovation and flexibility of iCON platform,” said Maik Jornitz, CEO of G-CON. “In our work together, we have all found that there is a rising demand for flexible facilities in our industry. The iCON turnkey facility platform addresses these needs and fulfills them.”

“iCON™ was conceived around a mission to deliver life enhancing products to patients,” said Tom Piombino, Biotechnology Process Architect & Sr. Director at IPS. “The pharmaceutical industry needs innovative thinking more than ever; IPS and G-CON are here to deliver on that. We are excited that MilliporeSigma has selected iCON™ to support their 2000L E2E platform and importantly, that they share in our vision to provide end to end solutions that support our customers and their patients.”

The hallmarks of the combined solution will be pre-fabricated cleanroom units, a structural platform based on cost effective pre-engineered building delivery, bioprocess and single-use equipment expertise, and turnkey facility capable of fast track deployment.

About IPS
IPS is a global leader in developing innovative facility and bioprocess solutions to the biopharmaceutical industry. Headquartered in Blue Bell, PA-USA, IPS is one of the largest multi-national companies focused on life sciences, with over 1,000 EPCM/CQV professionals and with offices in the US, Canada, Brazil, United Kingdom, Ireland, Switzerland, Singapore, China and India. Please visit our website at http://www.ipsdb.com.

About G-CON
G-CON Manufacturing designs, builds and installs prefabricated, autonomous cleanroom PODs®. G-CON’s cleanroom POD® portfolio encompasses a variety of different dimensions and purposes, from laboratory environments to personalized medicine and production process platforms. POD® cleanroom units surpass traditional cleanroom structures by virtue of their scalability, mobility and the possibility of repurposing the PODs® once the production process reaches its lifecycle end. For more information, please visit G-CON’s website at http://www.gconbio.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brittany Berryman

Ana Maria Collins
@G_CON_PODs
Follow >
G-CON Manufacturing, Inc.
since: 12/2014
Like >
G-CON Manufacturing, Inc.

Follow us on
Visit website